Suzhou, China · Founded 2020 · Privately Held (backing)
Developer of a pulsed field ablation (PFA) system intended to treat Atrial fibrillation (A-fib). AccuPulse is based in Suzhou, China and was founded in 2020. It has raised $64.6 million.
Last price · $/share
—
Implied valuation
—
Total raised
$64.6M
Last round
—
Team — not yet on record
No current team members for AccuPulse are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of AccuPulse with a free account
·Watch AccuPulse: the Monday email on marks, rounds and moves
